MiniMed (Nasdaq:MMED) announced today that it received CE mark for the use of its MiniMed 780G with the Instinct sensor made by Abbott. Northridge, California-based MiniMed — which just went public as part of its separation from Medtronic — now offers more sensor choices for users of its most advanced automated insulin delivery system. The […]
Medtronic
MiniMed completes $538M IPO, retains $309M in proceeds as Medtronic separation takes shape
MiniMed (Nasdaq:MMED) announced today that it completed its previously announced initial public offering (IPO). Shares of MMED began trading on Friday, March 6, following the pricing of the IPO that day. They closed today, March 9, down 2.7% at $18 apiece. The Medtronic Diabetes unit priced its IPO at $20 per share, offering 28 million […]
MiniMed expects to close $644M IPO next week ahead of Medtronic split
MiniMed has set the price for its planned initial public offering (IPO) ahead of an imminent separation from Medtronic (NYSE:MDT). The Medtronic Diabetes unit’s IPO includes 28 million shares of common stock priced at $20 apiece, amounting to $560 million. Underwriters also have an option to purchase up to 4.2 million additional shares at the […]
Medtronic launches MiniMed Go smart MDI system with Simplera sensor in Europe
Medtronic (NYSE:MDT) announced today that it launched its MiniMed Go smart multiple daily injection (MDI) system with the Simplera sensor. The system represents the first and only solution that integrates data from the InPen smart insulin pen and the Simplera continuous glucose monitor (CGM) sensor into a single mobile app. Medtronic (soon to separate its Diabetes […]
Medtronic MiniMed Diabetes IPO could reach up to $784M
In an amendment to an SEC filing, Medtronic’s (NYSE:MDT) Diabetes unit, MiniMed, today shared more details on its planned initial public offering (IPO). Medtronic announced in May that it planned to separate the Diabetes unit into a standalone, publicly traded company. In that announcement, the company projected the separation within the next 18 months. It […]
Medtronic Diabetes to lay off 81 employees ahead of MiniMed separation
Medtronic (NYSE:MDT) is cutting 81 jobs from its Diabetes unit ahead of its planned separation into MiniMed. A Worker Adjustment and Retraining Notification (WARN) notice filed in California confirms the company’s plans to lay off 81 employees at its Northridge facility. MedTech Dive reported the news first. The notice states that Medtronic notified the state of the […]
Medtronic submits MiniMed Flex to FDA, Diabetes separation is on track amid strong Q4
Medtronic (NYSE:MDT) said today that the separation of its MiniMed Diabetes unit remains on track as it advances the MiniMed Flex system. On the company’s third-quarter earnings call, CFO Thierry Piéton explained the business’ performance as it works toward completing an IPO — for which it filed at the end of 2025 — and bringing […]
Medtronic earns Medicare, FDA wins for MiniMed 780G with Instinct sensor, including for type 2 diabetes
Medtronic (NYSE:MDT) today announced three U.S. milestones expanding access to its MiniMed 780G automated insulin delivery system. The company announced Medicare access for MiniMed 780G paired with the Instinct sensor made by Abbott, FDA clearance for the pairing for insulin-requiring type 2 diabetes and FDA clearance for the system’s use with ultra rapid-acting insulins. Medtronic […]
Medtronic wins FDA clearance for MiniMed Go app for InPen smart insulin pen
Medtronic (NYSE:MDT) announced today that the FDA granted 510(k) clearance for its MiniMed Go app for multiple daily injections (MDI). MiniMed Go, a smart MDI system, integrates the InPen smart insulin pen with the Instinct sensor made by Abbott. It all integrates within the app to deliver real-time, personalized insights and actionable guidance. Medtronic and […]
Medtronic expands US pharmacy formulary access for MiniMed 780G
Medtronic (NYSE:MDT) announced today that it expanded U.S. pharmacy formulary access for its MiniMed 780G insulin pump. The medtech giant’s Diabetes business unit — set to become a standalone public company called MiniMed through an IPO — said it struck agreements with major pharmacy benefit managers (PBMs) and PBM group purchasing organizations (GPOs), including Ascent and […]
